iSpecimen Inc
NASDAQ:ISPC
iSpecimen Inc
Operating Income
iSpecimen Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
iSpecimen Inc
NASDAQ:ISPC
|
Operating Income
-$11.2m
|
CAGR 3-Years
-67%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
Veeva Systems Inc
NYSE:VEEV
|
Operating Income
$429.3m
|
CAGR 3-Years
4%
|
CAGR 5-Years
14%
|
CAGR 10-Years
27%
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Operating Income
-$40.3m
|
CAGR 3-Years
11%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
Evolent Health Inc
NYSE:EVH
|
Operating Income
$12.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Doximity Inc
NYSE:DOCS
|
Operating Income
$125.1m
|
CAGR 3-Years
78%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Certara Inc
NASDAQ:CERT
|
Operating Income
$6.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is iSpecimen Inc's Operating Income?
Operating Income
-11.2m
USD
Based on the financial report for Dec 31, 2023, iSpecimen Inc's Operating Income amounts to -11.2m USD.
What is iSpecimen Inc's Operating Income growth rate?
Operating Income CAGR 5Y
-27%
Over the last year, the Operating Income growth was -14%. The average annual Operating Income growth rates for iSpecimen Inc have been -67% over the past three years , -27% over the past five years .